NCT06179030View on ClinicalTrials.gov

Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Diabetic Macular EdemaInflammation
Interventions
DIAGNOSTIC_TEST

serum samples

The serum samples were taken from the patients at the 3rd month (switch point)

DRUG

dexamethasone implant versus ranibizumab

dexamethasone implant versus ranibizumab will be studied as a secondary outcome

Trial Locations (1)

34384

Prof. Dr. Cemil Tascioglu City Hospital, Istanbul

All Listed Sponsors
lead

Saglik Bilimleri Universitesi

OTHER